West Pharmaceutical Services, Inc. WST
370.44
(3.16)
(0.85%)
as of 25 Sep
- Market cap
- $26.3B
- P/E
- 47.1×
Follow WST
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
16.94% | 16.85% | 19.13% | 19.09% | |
| 12.64% | 12.48% | 14.05% | 14.07% | ||
ROIC |
13.99% | 14.13% | 15.32% | 15.42% | |
Return on Tangible Assets |
16.79% | 16.19% | 19.01% | 19.80% | |
Average Days of Receivables |
75.59 | 68.20 | 77.69 | 78.12 | |
Free Cash Flow per Share |
5.25 | 6.49 | 6.36 | 6.17 | |
Free Cash Flow |
379.10 | 468.90 | 458.00 | 436.90 | |
Capital Expenditures |
(314.70) | (285.90) | (257.30) | (225.30) | |
Piotroski F-Score |
6.00 | 7.00 | 7.00 | 8.00 | |
| Other line items | |||||
Cash ROIC |
17.87% | 18.10% | 19.26% | 18.25% | |
Accounts Receivable Turnover |
5.25 | 5.46 | 5.24 | 5.14 | |
Accounts Payable Turnover |
8.10 | 7.99 | 8.54 | 8.55 | |
Inventory Turnover |
4.63 | 4.80 | 4.88 | 4.84 | |
Average Days of Payables |
48.02 | 47.00 | 44.87 | 43.86 | |
Days of Inventory on Hand |
82.23 | 82.24 | 80.49 | 77.65 | |
Tax Rate |
(0.21) | (0.20) | (0.21) | (0.21) | |
Research and Development Expense of Revenue |
2.35% | 2.42% | 2.29% | 2.24% | |
Selling, General and Administrative Expense of Revenue |
12.32% | 12.80% | 12.58% | 12.83% | |
Share Based Compensation of Revenue |
0.71% | 0.77% | 0.90% | 0.98% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.41 | 1.53 | 1.32 | 1.17 | |
Depreciation/Fixed assets |
0.09 | 0.10 | 0.10 | 0.11 | |
Capex/Depreciation |
(1.91) | (1.67) | (1.46) | (1.24) | |
Revenue per Share |
41.80 | 42.52 | 44.74 | 46.99 | |
Operating CF per Share |
9.61 | 10.44 | 9.93 | 9.35 | |
Capex per Share |
(4.36) | (3.95) | (3.57) | (3.18) | |
Capex to Sales |
0.10 | 0.09 | 0.08 | 0.07 | |
Net Profit Margin |
16.29% | 16.06% | 16.85% | 16.98% |
Columns are period end dates